SLGC
Somalogic Inc
NASDAQ: SLGC · HEALTHCARE · HEALTH INFORMATION SERVICES
$9.90
+0.00% today
Updated 2026-04-30
Market cap
$396.23M
P/E ratio
—
P/S ratio
4.85x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$19 – $20
Volume
1.1M
Somalogic Inc (SLGC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | $32.19M | $55.89M | $81.63M | $97.67M | $81.72M |
| Revenue growth (YoY) | — | +73.6% | +46.1% | +19.7% | -16.3% |
| Cost of revenue | $49.72M | $22.61M | $33.46M | $43.36M | $48.09M |
| Gross profit | $-17.53M | $33.27M | $48.16M | $54.30M | $33.63M |
| Gross margin | -54.5% | 59.5% | 59.0% | 55.6% | 41.2% |
| R&D | $32.50M | $30.75M | $43.50M | $73.44M | $57.93M |
| SG&A | $33.32M | $36.68M | $77.27M | $153.12M | $128.24M |
| Operating income | $-50.96M | $-34.36M | $-73.30M | $-175.76M | $-152.53M |
| Operating margin | -158.3% | -61.5% | -89.8% | -180.0% | -186.6% |
| EBITDA | $-47.80M | $-31.53M | $-86.00M | $-175.76M | — |
| EBITDA margin | -148.5% | -56.4% | -105.4% | -180.0% | 0.0% |
| EBIT | $-50.96M | $-34.59M | $-86.22M | $-183.81M | — |
| Interest expense | $0.00 | $18.34M | $1.32M | $109.25M | — |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-57.00M | $-71.35M | $-86.30M | $-109.16M | $-130.38M |
| Net income growth (YoY) | — | -25.2% | -21.0% | -26.5% | -19.4% |
| Profit margin | -177.1% | -127.7% | -105.7% | -111.8% | -159.5% |